Psoriasis drug offers treatment potential for type 1 diabetes

09/24/2013 | Medical News Today

The psoriasis drug alefacept was able to help the body produce its own insulin in a study of 49 patients with type 1 diabetes conducted by Indiana University and the Riley Hospital for Children in Indianapolis. Researchers identified alefacept because it targets the same specific T cells that attack insulin-producing cells in the pancreas of type 1 diabetes patients.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA